Logo image of ALAFY.PA

AFYREN SAS (ALAFY.PA) Stock Fundamental Analysis

Europe - EPA:ALAFY - FR0014005AC9 - Common Stock

2.31 EUR
+0.04 (+1.54%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALAFY. ALAFY was compared to 69 industry peers in the Chemicals industry. ALAFY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALAFY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALAFY had negative earnings in the past year.
In the past year ALAFY has reported a negative cash flow from operations.
ALAFY had negative earnings in each of the past 5 years.
ALAFY had a negative operating cash flow in each of the past 5 years.
ALAFY.PA Yearly Net Income VS EBIT VS OCF VS FCFALAFY.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

ALAFY's Return On Assets of -22.07% is on the low side compared to the rest of the industry. ALAFY is outperformed by 84.06% of its industry peers.
The Return On Equity of ALAFY (-24.60%) is worse than 81.16% of its industry peers.
Industry RankSector Rank
ROA -22.07%
ROE -24.6%
ROIC N/A
ROA(3y)-13.7%
ROA(5y)-10.19%
ROE(3y)-15.66%
ROE(5y)-12.5%
ROIC(3y)N/A
ROIC(5y)N/A
ALAFY.PA Yearly ROA, ROE, ROICALAFY.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 89.71%, ALAFY belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
ALAFY's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALAFY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5Y-1.95%
ALAFY.PA Yearly Profit, Operating, Gross MarginsALAFY.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

6

2. Health

2.1 Basic Checks

ALAFY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALAFY has been increased compared to 1 year ago.
Compared to 5 years ago, ALAFY has more shares outstanding
ALAFY has a better debt/assets ratio than last year.
ALAFY.PA Yearly Shares OutstandingALAFY.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ALAFY.PA Yearly Total Debt VS Total AssetsALAFY.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ALAFY has an Altman-Z score of 6.32. This indicates that ALAFY is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.32, ALAFY belongs to the best of the industry, outperforming 95.65% of the companies in the same industry.
ALAFY has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
ALAFY's Debt to Equity ratio of 0.03 is amongst the best of the industry. ALAFY outperforms 92.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 6.32
ROIC/WACCN/A
WACC7.68%
ALAFY.PA Yearly LT Debt VS Equity VS FCFALAFY.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

ALAFY has a Current Ratio of 14.79. This indicates that ALAFY is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ALAFY (14.79) is better than 100.00% of its industry peers.
ALAFY has a Quick Ratio of 14.79. This indicates that ALAFY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 14.79, ALAFY belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 14.79
Quick Ratio 14.79
ALAFY.PA Yearly Current Assets VS Current LiabilitesALAFY.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

ALAFY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.72%.
ALAFY shows a decrease in Revenue. In the last year, the revenue decreased by -3.05%.
Measured over the past years, ALAFY shows a small growth in Revenue. The Revenue has been growing by 4.31% on average per year.
EPS 1Y (TTM)-15.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.81%
Revenue 1Y (TTM)-3.05%
Revenue growth 3Y-1.95%
Revenue growth 5Y4.31%
Sales Q2Q%-11.73%

3.2 Future

Based on estimates for the next years, ALAFY will show a small growth in Earnings Per Share. The EPS will grow by 6.59% on average per year.
ALAFY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 92.86% yearly.
EPS Next Y-12.22%
EPS Next 2Y1.11%
EPS Next 3Y6.59%
EPS Next 5YN/A
Revenue Next Year-5.8%
Revenue Next 2Y-2.94%
Revenue Next 3Y92.86%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALAFY.PA Yearly Revenue VS EstimatesALAFY.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M 25M
ALAFY.PA Yearly EPS VS EstimatesALAFY.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALAFY. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALAFY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALAFY.PA Price Earnings VS Forward Price EarningsALAFY.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALAFY.PA Per share dataALAFY.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.11%
EPS Next 3Y6.59%

More info and screens

0

5. Dividend

5.1 Amount

ALAFY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AFYREN SAS

EPA:ALAFY (10/16/2025, 7:00:00 PM)

2.31

+0.04 (+1.54%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners12.35%
Inst Owner ChangeN/A
Ins Owners10.68%
Ins Owner ChangeN/A
Market Cap60.31M
Analysts86
Price Target5.3 (129.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-40.28%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-26.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 22.32
P/FCF N/A
P/OCF N/A
P/B 1.31
P/tB 1.39
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0.1
BVpS1.77
TBVpS1.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.07%
ROE -24.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.71%
FCFM N/A
ROA(3y)-13.7%
ROA(5y)-10.19%
ROE(3y)-15.66%
ROE(5y)-12.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5Y-1.95%
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 31.49%
Cap/Sales 10.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.79
Quick Ratio 14.79
Altman-Z 6.32
F-Score5
WACC7.68%
ROIC/WACCN/A
Cap/Depr(3y)59.69%
Cap/Depr(5y)64.66%
Cap/Sales(3y)13.21%
Cap/Sales(5y)12.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.81%
EPS Next Y-12.22%
EPS Next 2Y1.11%
EPS Next 3Y6.59%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.05%
Revenue growth 3Y-1.95%
Revenue growth 5Y4.31%
Sales Q2Q%-11.73%
Revenue Next Year-5.8%
Revenue Next 2Y-2.94%
Revenue Next 3Y92.86%
Revenue Next 5YN/A
EBIT growth 1Y4.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50.45%
EBIT Next 3Y13.43%
EBIT Next 5YN/A
FCF growth 1Y-10.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.22%
OCF growth 3YN/A
OCF growth 5YN/A